吸入用布地奈德混悬液联合特布他林治疗慢性阻塞性肺疾病急性加重期的效果分析

Efficacy Analysis of Budesonide Suspension for Inhalation Combined with Terbutaline in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的以我院确诊的慢性阻塞性肺疾病急性加重期患者为研究对象,实施吸入用布地奈德混悬液联合特布他林治疗,分析应用价值。方法选取我院2019年3月至2020年5月治疗的72例患者为例,依据双盲法均分为对照组与观察组,每组各36例。对照组实施常规治疗,观察组实施吸入用布地奈德混悬液联合特布他林治疗。对比两组疗效与治疗前后的肺功能、炎性因子指标。结果两组治疗总有效率比较,观察组为94.44%,对照组为69.44%(P<0.05);两组肺功能指标比较,治疗后观察组高于对照组(P<0.05);两组炎性因子比较,观察组低于对照组(P<0.05)。结论针对慢性阻塞性肺疾病急性加重期患者实施联合治疗,可有效改善患者肺功能,调节患者炎性反应,提高治疗效果。

Objective To analyze the application value of budesonide suspension for inhalation plus terbutaline in patients with acute exacerbation of chronic obstructive pulmonary disease diagnosed in our hospital.Methods Seventy-two patients treated in our hospital from March 2019 to May 2020 were selected as examples and divided into control group and observation group according to double-blind method,with 36 cases in each group.The control group received routine treatment,while the observation group received budesonide suspension for inhalation plus terbutaline.The curative effect of the two groups was compared with the lung function and inflammatory factors before and after treatment.Results The total effective rate of two groups was 94.44%in observation group and 69.44%in control group(P<0.05).After treatment,the indexes of lung function in the observation group were higher than those in the control group(P<0.05).The inflammatory factors in the observation group were lower than those in the control group(P<0.05).Conclusion Combined treatment for patients with acute exacerbation of chronic obstructive pulmonary disease can effectively improve the pulmonary function,regulate the inflammatory reaction and improve the therapeutic effect.